Kaposi's Sarcoma Associated Herpesvirus Tegument Protein ORF75 Is Essential for Viral Lytic Replication and Plays a Critical Role in the Antagonization of ND10-Instituted Intrinsic Immunity

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  Full, Florian ^a,e   Jungnickl, Doris ^a   Reuter, Nina ^a   Bogner, Elke ^b   Brulois, Kevin ^c   Scholz, Brigitte ^a   Stürzl, Michael ^a   Myoung, Jinjong ^d,f   Jung, Jae U ^c   Stamminger, Thomas ^a   Ensser, Armin ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATRX PROTEIN, HUMAN; DAXX PROTEIN, HUMAN; DNA HELICASE; NUCLEAR DOT PROTEIN 52, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STOP CODON; VIRUS PROTEIN;

CELL CULTURE; GENE SILENCING; GENETICS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOLOGY; INNATE IMMUNITY; MALE; MUTATION; PATHOLOGY; PHYSIOLOGY; STOP CODON; VIRUS REPLICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELLS, CULTURED; CODON, TERMINATOR; DNA HELICASES; GENE KNOCKDOWN TECHNIQUES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNITY, INNATE; MALE; MUTATION; NUCLEAR PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84893715483     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003863     Document Type: Article

References (44)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
2. Dupin N, Grandadam M, Calvez V, Gorin I, Aubin JT, et al. (1995) Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345: 761-762.
3. Ganem D, (2010) KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120: 939-949.
4. Tavalai N, Stamminger T, (2008) New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 1783: 2207-2221.
5. Maul GG, Guldner HH, Spivack JG, (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol 74 (Pt 12) (): 2679-2690.
6. Boutell C, Sadis S, Everett RD, (2002) Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76: 841-850.
7. Boutell C, Cuchet-Lourenco D, Vanni E, Orr A, Glass M, et al. (2011) A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog 7: e1002245.
8. Lee HR, Kim DJ, Lee JM, Choi CY, Ahn BY, et al. (2004) Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol 78: 6527-6542.
9. Muller S, Dejean A, (1999) Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol 73: 5137-5143.
10. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venturini L, et al. (1995) Induction of the PML protein by interferons in normal and APL cells. Leukemia 9: 2027-2033.
11. Grotzinger T, Sternsdorf T, Jensen K, Will H, (1996) Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem 238: 554-560.
12. Katano H, Ogawa-Goto K, Hasegawa H, Kurata T, Sata T, (2001) Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies. Virology 286: 446-455.
13. Marcos-Villar L, Lopitz-Otsoa F, Gallego P, Munoz-Fontela C, Gonzalez-Santamaria J, et al. (2009) Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J Virol 83: 8849-8858.
14. Chang PC, Izumiya Y, Wu CY, Fitzgerald LD, Campbell M, et al. (2010) Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J Biol Chem 285: 5266-5273.
15. Wu FY, Ahn JH, Alcendor DJ, Jang WJ, Xiao J, et al. (2001) Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J Virol 75: 1487-1506.
16. Full F, Reuter N, Zielke K, Stamminger T, Ensser A, (2012) Herpesvirus Saimiri Antagonizes Nuclear Domain 10-Instituted Intrinsic Immunity via an ORF3-Mediated Selective Degradation of Cellular Protein Sp100. J Virol 86: 3541-3553.
17. Ling PD, Tan J, Sewatanon J, Peng R, (2008) Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol 82: 8000-8012.
18. Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse HJ, Lieberman PM, (2011) EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog 7: e1002376.
19. Konrad A, Wies E, Thurau M, Marquardt G, Naschberger E, et al. (2009) A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol 83: 2563-2574.
20. Vieira J, O'Hearn PM, (2004) Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325: 225-240.
21. Myoung J, Ganem D, (2011) Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174: 12-21.
22. Stürzl M, Gaus D, Dirks WG, Ganem D, Jochmann R, (2013) Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line. Int J Cancer 132: 1954-1958.
23. Bechtel JT, Winant RC, Ganem D, (2005) Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 79: 4952-4964.
24. Rozen R, Sathish N, Li Y, Yuan Y, (2008) Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus. J Virol 82: 4742-4750.
25. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, et al. (2012) Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86: 9708-9720.
26. Gaspar M, Gill MB, Losing JB, May JS, Stevenson PG, (2008) Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS ONE 3: e2781.
27. Günther T, Grundhoff A, (2010) The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6: e1000935.
28. Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, et al. (2010) Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6: e1001013.
29. Marcos-Villar L, Campagna M, Lopitz-Otsoa F, Gallego P, Gonzalez-Santamaria J, et al. (2011) Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. J Gen Virol 92: 188-194.
30. Joo CH, Shin YC, Gack M, Wu L, Levy D, et al. (2007) Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J Virol 81: 8282-8292.
31. Jacobs SR, Damania B, (2011) The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes? Front Immunol 2: 19.
32. Schmidt K, Wies E, Neipel F, (2011) Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression. J Virol 85: 4530-4537.
33. Orenstein JM, Alkan S, Blauvelt A, Jeang KT, Weinstein MD, et al. (1997) Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11: F35-F45.
34. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, et al. (1997) Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71: 715-719.
35. Grundhoff A, Ganem D, (2004) Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113: 124-136.
36. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, et al. (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340: 1063-1070.
37. Jahn G, Knust E, Schmolla H, Sarre T, Nelson JA, et al. (1984) Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol 49: 363-370.
38. Adler M, Tavalai N, Müller R, Stamminger T, (2011) Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100. J Gen Virol 92: 1532-1538.
39. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T, (2006) Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80: 8006-8018.
40. Tavalai N, Adler M, Scherer M, Riedl Y, Stamminger T, (2011) Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol 85: 9447-9458.
41. Tischer BK, von Einem J, Kaufer B, Osterrieder N, (2006) Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 40: 191-197.
42. Tischer BK, Smith GA, Osterrieder N, (2010) En passant mutagenesis: a two step markerless red recombination system. Methods Mol Biol 634: 421-430.
43. Zhang Y, Buchholz F, Muyrers JP, Stewart AF, (1998) A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20: 123-128.
44. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, et al. (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676-682.